There is considerable experimental evidence that asbestos fibres are taken up by epithelial cells, and that uptake offibres is associated with various deleterious, particularly mutagenic, effects. It is not known, however, if asbestos fibres are taken up by human bronchial epithelial cells in vivo. To investigate this question, the amosite asbestos content of the mucosa of seven different airways and four parenchymal sites supplied by these airways in six necropsy lungs from heavily exposed never-smoking long term shipyard and insulation workers without asbestosis was examined. Amosite asbestos was readily found in moderately high concentration in all parenchymal samples, but 33 of 40 airway samples that could be evaluated showed no amosite fibres. The seven positive airways had fibre concentrations that were always much lower than the parenchymal concentrations, and these very few fibres may have been contaminants from the parenchyma. These data suggest that, at least in non-smokers, amosite asbestos either does not penetrate into or does not accumulate in human airway mucosa. These findings also call into question the idea that asbestos acts as a direct airway carcinogen in humans.
In general asbestos seems to produce disease through various locally mediated rather than systemic effects. The most consistent findings in experimental animal and tissue culture systems have been that epithelial cells take up asbestos fibres, and that fibre uptake is associated with deleterious effects relating to both fibrogenesis and carcinogenesis'-3 (see discussion).
Although fibre uptake by bronchial epithelial cells is well established in experimental models, it is not known to what degree the same process occurs in humans, or even whether it occurs at all. We have recently devised a technique for analysing the particle content of respiratory bronchial mucosa from human necropsies,4 and in this paper we apply the technique to look at airway and parenchymal asbestos retention in workers with substantial occupational exposure to amosite asbestos.
Materials and methods

CASE SELECTION
Cases for this study were selected from persons with occupational exposure to amosite asbestos whose lungs at necropsies were referred to this laboratory for evaluation of asbestos content. These persons had been exposed to asbestos in the Pacific north west in shipyards or as career asbestos insulators and similar trades in which high level asbestos exposure was known to have occurred.
As this study was intended to provide baseline data on fibre burden in the airway mucosa free of interference by variables that might affect fibre retention, we restricted the study to lungs that were essentially pathologically normal. Small amounts of pneumonia were considered acceptable. We also decided to restrict the study to non-smokers because smoking may change fibre uptake.5 Because we did not know which airways were likely to accumulate asbestos fibres and because we needed to ensure a broad sample of airways, analyses were restricted to lungs in which several different airways matching the scheme shown could be found. Lastly, to ensure that the population sampled had a reasonably heavy exposure, only cases with greater than 10 years of exposure were used.
TISSUE SAMPLING
Application of the conditions just described resulted in selection of six lungs, all of which turned out to be from patients with mesothelioma. Only the lung The parenchymal samples consisted of wedge shaped pieces of tissue based on the pleura and with the apex of the wedge extending to the site of the sample of segmental airway.
PREPARATION OF TISSUE FOR ASBESTOS AND PARTICLE IDENTIFICATION
Airway or parenchymal samples were dissolved in bleach and the mineral particles collected on millipore filters and then transferred to coated electron microscope grids as previously described. 6 Preparations were examined in a Phillips 400T electron microscope equipped with a Kevex energy dispersive x ray spectrometer. For the parenchymal samples, 50 randomly selected grid squares were evaluated and all amosite fibres identified and measured. For the airway samples, 50 grid squares were initially evaluated, but, because this examination failed to find amosite fibres in any of the airway sites, a further 250 grid squares for a total of 300 squares was examined for each sample. This number was chosen both to provide low detection limits (see below) and as a practical matter because of the extensive time involved in counting this many squares.
When it became apparent that even examination of 300 grid squares failed to show asbestos in most airway sites, a decision was made to count total mineral particles using the same grids. This count was intended as a positive control to indicate whether the preparations were faulty, or whether in fact the asbestos content of the airways was extremely low.
Results were calculated using an algorithm that relates weight of tissue dissolved and number of grid squares examined.6 All results were expressed in terms offibres or particles/g dry tissue. The detection limit for each sample is defined as the number of fibers/g dry tissue that would be represented by the finding of 1 actual fibre in the counted grid squares (this indicates the minimum sensitivity of the technique (see discussion). Because many of the distributions shown in tables 2 and 4 are skewed, as is common with particle counts, both arithmetic and geometric mean values were calculated for presenta- Amosite concentration in thousands of fibres/g dry tissue; Total particle concentrations in millions of particles/g dry tissue; Symbol <:
less than indicated detection limit, ND = not analysed; A = amosite; P = particles. Table 2 shows these data for each case. The symbol < indicates that no fibres were found, and that the possible concentration (if any) was therefore less than the indicated detection limit. In two cases one airway site was not usable so that the total number of sampled airways was 40. Amosite fibres were detected in only seven of the 40 sample sites; no particular airway was consistently positive for asbestos fibres. When present airway amosite concentrations ranged from 35 000 to 120 000 fibres/g dry tissue. Nonasbestos mineral particles were present in all airways in concentrations ranging between 20 and 400 million particles/g dry tissue. Table 3 shows arithmetic and geometric mean summary data. Treating the airways with no detectable fibres as concentration Table 4 Amosite asbestos and total particle concentration in parenchyma APT  210  350  160  470  480  260  540  560  340  200  360  200  AST  380  180  390  730  ND  ND  270  340  390  260  190  84   SST  230  300  63  100  140  130  430  330  590  190  ND  ND  PBT  140  160  67  160  100  260  260  270  270  260  790  240 Amosite concentration in thousands of fibres/g dry tissue; Total particle concentrations in millions of particles/g dry tissue; ND = not analysed; A = amosite; P = particles.
the penetration of asbestos fibres into epithelial cells are thus clear, but despite extensive experimental work in this area, there are no data available on whether asbestos actually enters human respiratory epithelial cells in vivo. It is known from animal model systems that inhaled mineral particles not removed by macrophages may penetrate into the respiratory epithelium and be transported through the cell to end up in the underlying interstitial tissue, from which site they are probably cleared poorly or not at all."7 18 Thus numbers of particles found in the respiratory mucosa (all tissues between the cartilage of the large airways and the epithelial surface) could potentially be used to determine patterns of particle retention in humans. In a study of airway mucosa from nonsmoking members of the general population,4 we found that the airway mucosa contained exogenous mineral particles of the order of 107 to 108/g dry tissue, and that the pattern of retention in terms of airway size and distance from the carina matched that predicted from theoretical models of particle deposition,'9 suggesting that in fact particles retained in the airway walls are probably excellent indicators not only of retention but also of initial deposition patterns.
We have now applied this technique to examine the question as to whether asbestos fibres enter the epithelium and walls ofthe larger conducting airways in human lungs. The population we have used was one with fairly substantial historic exposure to asbestos, exposure sufficient to cause mesotheliomas, and sufficient to produce readily dectectable fibre concentrations in the parenchyma. We found that no fibres could be detected in 83% of the bronchial sample sites despite the presence of large numbers of nonasbestos particles in the same samples. In fact the non-asbestos particle concentrations in these airways showed the same pattern that we have previously reported4-namely, higher concentrations in segmental compared to mainstem or upper and lower lobe bronchi (table 3) . These findings indicate that the technique was working properly and that the aparent absence of asbestos fibres from the airways is not an analytical artifact. Even in the positive airway samples only one or at most two fibres were found in 300 grid squares, and it is entirely possible that these few fibres are contaminants from the much larger number of fibres present in the parenchyma (the actual number of fibres counted in 50 squares in the parenchymal sites varied from 14 to 50, mean 35).
It should be noted that the word "absence" is not strictly correct in this context; the more accurate conclusion is that amosite fibres, if present, might be present at any level below the detection limit. But in terms of fibre burdens found in patients with occupational exposure to amosite exposure, the potential maximum burdens represented by the detection limits (average about 40 000 fibres/g) or by the actual number of fibres (average about 11 000 fibres/g, treating the airways with no detectable fibres as value 0) in the airway mucosa are extraordinarily low. This fact can be best appreciated by noting that the average fibre concentration in the parenchymal samples supplied by these same airways was about 600 000 fibres/g dry lung, a value typical of that we found in workers with mesothelioma. 20 By contrast, members of the general population usually carry no more than 10 000 fibres of amosite/g of parenchyma, values fairly similar to the detection limits just mentioned.
It thus seems that the airway mucosa in humans may not accumulate many amosite asbestos fibres, but this conclusion must be made with considerable caution. For one thing, the number of cases examined is obviously small, although the fairly large number of sampled airways partly makes up for this problem. Although the persons in our study have had substantial exposure, groups of workers with considerably higher exposure do exist: in our laboratory lungs with amosite induced asbestosis typically have 10 to 100 times the fibre load found in lungs with mesothelioma, the lungs used in this study.20 The 
